Rituximab treatment in a patient with severe thyroid-associated ophthalmopathy: Effects on orbital lymphocytic infiltrates-Reference-Cited by-同舟云学术

Rituximab treatment in a patient with severe thyroid-associated ophthalmopathy: Effects on orbital lymphocytic infiltrates

Published:2009-05 Issue:2 Volume:131 Page:360-365
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Salvi Mario,Vannucchi Guia,Campi Irene,Currò Nicola,Simonetta Simona,Covelli Danila,Pignataro Lorenzo,Guastella Claudio,Rossi Stefania,Bonara Paola,Dazzi Davide,Ratiglia Roberto,Beck-Peccoz Paolo

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference29 articles.

1. Cellubrevin-targeted Fluorescence Uncovers Heterogeneity in the Recycling Endosomes

2. T helper type 1 and type 2 cytokines exert divergent influence on the induction of prostaglandin E2 and hyaluronan synthesis by interleukin-1 beta in orbital fibroblasts: implications for the pathogenesis of thyroid-associated ophthalmopathy;Han;Endocrinology,2006

3. Pathogenesis of Graves' ophthalmopathy: implications for prediction, prevention and treatment;Garrity;Am. J. Ophthalmol.,2006

4. TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients;Wakelkamp;Clin. Endocrinol.,2003

5. Smoking and thyroid-associated ophthalmopathy: a novel explanation of the biological link;Cawood;J. Clin. Endocrinol. Metab.,2007

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alemtuzumab-induced thyroid eye disease successfully treated with a single low-dose of rituximab;European Thyroid Journal;2024-03

2. Orbital lymphocyte populations in three states of thyroid eye disease;American Journal of Ophthalmology Case Reports;2023-09

3. Dysthyroid optic neuropathy: emerging treatment strategies;Journal of Endocrinological Investigation;2023-02-18

4. Diagnosis and Management of Dysthyroid Optic Neuropathy;International Ophthalmology Clinics;2023

5. Rituximab for thyroid-associated ophthalmopathy;Cochrane Database of Systematic Reviews;2022-06-16